Injectable Antibiotic, Drug Exposure

This broad concept set was developed to identify injectable antibiotic exposures for a cohort of neonates. The medication codes were compiled using RxNorm at the Clinical Dose Form Group level containing the injectable version of specific antibiotic ingredients, including: amikacin Injectable Product cilastatin / imipenem Injectable Product cefamandole Injectable Product cefazolin Injectable Product cefoperazone Injectable Product cefotaxime Injectable Product cefotetan Injectable Product cefoxitin Injectable Product ceftazidime Injectable Product ceftizoxime Injectable Product ceftriaxone Injectable Product cefuroxime Injectable Product ampicillin / sulbactam Injectable Product ampicillin Injectable Product azithromycin Injectable Product aztreonam Injectable Product tobramycin Injectable Product piperacillin / tazobactam Injectable Product piperacillin Injectable Product itraconazole Injectable Product vancomycin Injectable Product cefepime Injectable Product doripenem Injectable Product ertapenem Injectable Product erythromycin Injectable Product penicillin G Injectable Product meropenem Injectable Product ceftolozane / tazobactam Injectable Product avibactam / ceftazidime Injectable Product ceftaroline fosamil Injectable Product gentamicin Injectable Product